ION Acquisition Corp 3 Ltd. (IACC): Price and Financial Metrics
GET POWR RATINGS... FREE!
IACC Stock Price Chart Interactive Chart >
IACC Price/Volume Stats
|Current price||$9.72||52-week high||$10.02|
|Prev. close||$9.73||52-week low||$9.64|
|Day high||$9.72||Avg. volume||43,788|
|50-day MA||$9.74||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||253.26M|
ION Acquisition Corp 3 Ltd. (IACC) Company Bio
ION Acquisition Corp 3 Ltd. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Herzliya, Israel.
Most Popular Stories View All
IACC Latest News Stream
|Loading, please wait...|
IACC Latest Social Stream
View Full IACC Social Stream
Latest IACC News From Around the Web
Below are the latest news stories about ION Acquisition Corp 3 Ltd that investors may wish to consider to help them evaluate IACC as an investment opportunity.
Day One Receives Orphan Designation from the European Commission for DAY101 for the Treatment of Glioma
SOUTH SAN FRANCISCO, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers, today announced that the European Commission has granted orphan designation for the Company’s lead product candidate, DAY101, for the treatment of glioma. The designation was based on a positive opinion from the European Medicines Agency Commit
ION Acquisition Corp 3 Ltd. Completes $253 Million Initial Public Offering
IACC Price Returns